Agent useful e.g. as lubricant, comprises e.g. substituted imidazolium alkyl sulfate compound, 2-prop-2-ynyloxy-ethanol, aspartic acid, 1-ethyl-3-methylimidazolium diethyl phosphate and 1-butyl-3-methylimidazolium trifluoromethanesulfonate
Agent comprises (a) at least one substituted imidazolium alkyl sulfate compound (I), (b) 1H-4(5)-methylbenzotriazole, (c) 2-prop-2-ynyloxy-ethanol, (d) poly[2-(methacryloyloxy)ethyl]trimethylammonium-bis(trifluoromethanesulfonyl)imide, (e) aspartic acid, (f) 1-ethyl-3-methylimidazolium diethyl phosp...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Agent comprises (a) at least one substituted imidazolium alkyl sulfate compound (I), (b) 1H-4(5)-methylbenzotriazole, (c) 2-prop-2-ynyloxy-ethanol, (d) poly[2-(methacryloyloxy)ethyl]trimethylammonium-bis(trifluoromethanesulfonyl)imide, (e) aspartic acid, (f) 1-ethyl-3-methylimidazolium diethyl phosphate and (g) 1-butyl-3-methylimidazolium trifluoromethanesulfonate. Agent comprises (a) at least one substituted imidazolium alkyl sulfate compound of formula (I), (b) 1H-4(5)-methylbenzotriazole, (c) 2-prop-2-ynyloxy-ethanol, (d) poly[2-(methacryloyloxy)ethyl]trimethylammonium-bis(trifluoromethanesulfonyl)imide, (e) aspartic acid, (f) 1-ethyl-3-methylimidazolium diethyl phosphate and (g) 1-butyl-3-methylimidazolium trifluoromethanesulfonate. R : 1-12C alkyl; either R1, R4 : H, 1-20C alkyl or 2-20C alkenyl (containing at least one double bond) (all preferred), 2-20C alkynyl (containing at least one triple bond), 3-7C cycloalkyl (optionally mono- or polysubstituted by 1-6C alkyl), phenyl (optionally mono- or polysubstituted by alkyl), heteroaryl, heteroaryl-1-6C alkyl or aryl-1-6C alkyl, where R1 and R4 do not simultaneously represent H; and R2, R3, R5 : H, 1-20C alkyl, 2-20C alkenyl (containing at least one double bond), 2-20C alkynyl (containing at least one triple bond), 3-7C cycloalkyl (optionally mono- or polysubstituted by 1-6C alkyl), phenyl (optionally mono- or polysubstituted by alkyl), heteroaryl, heteroaryl-1-6C alkyl, aryl-1-6C alkyl, F, Cl, Br, I, CN, OR11, N(R11) 2, P(O)(R11) 2, P(O)(OR11) 2, P(O)(N(R11) 2) 2, C(O)R11, C(O)OR11, C(O)X, C(O)N(R11) 2, SO 2N(R11) 2, SO 2OH, SO 2X, SR11, S(O)R11, SO 2R11 or NO 2; or R11+R12+R13+R14+R15 : ring; R11 : H, 1-8C alkyl (non-fluorinated, partially fluorinated or perfluorinated and optionally branched), saturated 3-7C cycloalkyl or optionally substituted phenyl; and X : F, Cl or Br. An independent claim is also included for preparing the agent, comprising mixing the components (b)-(g) with (I) and optionally with further additives. [Image].
Die Erfindung betrifft ein Mittel enthaltend spezielle Imidazolium alkylsulfate und 1H-4/5-Methylbenzotriazol, 2-Prop-2-ynyloxy-ethanol, Poly[2-(Methacryloyloxy)ethyl]trimethylammonium bis(trifluormethansulfonyl)imid, Asparaginsäure, 1-Ethyl-3-methylimidazoliumdiethylphosphat, 1-Butyl-3-methylimidazolium trifluormethansulfonat, ein Verfahren zur Herstellung und die Verwendung von 1H-4/5-Methylbenzotriazol, 2-Prop-2-ynyloxy-ethanol, Poly[2-(Methacryloyloxy)ethyl]trimethylammo |
---|